Newswise — Cambridge, MA. Tues. April 29, 2014 – The Broad Institute of MIT and Harvard today announced the appointment of two new members to its senior leadership team, Chief Operating Officer Samantha Singer and Chief Communications Officer Clare Midgley. They join another recent addition, Chief Development Officer Justine Levin-Allerhand, who was recruited to the Broad last year. All three are members of the institute’s executive leadership team, where they drive and implement strategies for operations, communications, and development efforts to meet the Broad’s institutional goals.
“Samantha, Clare, and Justine each bring to the institute extensive experience and talent,” said Broad Institute Founding Director Eric Lander. “The Broad Institute has made amazing progress over the past ten years, growing from a small start-up to a major international research institution. The expansion of our leadership team reflects the accomplishments of the Broad and its ambitions for the next ten years.”
All three leaders bring deep expertise in critical areas to the institute:
Samantha Singer joins the Broad Institute from Biogen Idec, where she most recently served as Vice President for Corporate Strategy and Chief of Staff for the Chief Executive Officer. Over her six years at the company, she led corporate strategy efforts and oversaw major operations initiatives abroad. In her role as Chief Operating Officer, Singer will oversee the institute's human resources, finance, facilities, and information technology teams, in addition to the Office of Strategic Alliances and Partnering.
Clare Midgley, a veteran of the Cambridge biotechnology community, is an experienced communications strategist and leader. Before Midgley joined the Broad, she was a strategy consultant. Prior to that she was Vice President of Global Corporate Affairs for seven years at Millennium Pharmaceuticals, overseeing brand strategy, corporate communications, and investor relations. As Chief Communications Officer, Midgley will focus on strategic communications for enhancing the awareness and reputation of the Broad.
Singer and Midgley join another senior leader, Justine Levin-Allerhand, who was recruited to the Broad last year.
Justine Levin-Allerhand, a scientist by training, is an accomplished fundraiser with diverse experience in raising large gifts to support science and medicine, and working with donors both nationally and internationally. Prior to joining the Broad Institute in 2013 as Chief Development Officer, Levin-Allerhand was responsible for significant science fundraising initiatives at major research colleges and universities, including Yale University and Albert Einstein College of Medicine. As Chief Development Officer, Levin-Allerhand is responsible for expanding the institute’s fundraising program.
About the Broad Institute of MIT and Harvard
The Eli and Edythe L. Broad Institute of MIT and Harvard was launched in 2004 to empower this generation of creative scientists to transform medicine. The Broad Institute seeks to describe all the molecular components of life and their connections; discover the molecular basis of major human diseases; develop effective new approaches to diagnostics and therapeutics; and disseminate discoveries, tools, methods, and data openly to the entire scientific community.
Founded by MIT, Harvard, and its affiliated hospitals, and the visionary Los Angeles philanthropists Eli and Edythe L. Broad, the Broad Institute includes faculty, professional staff, and students from throughout the MIT and Harvard biomedical research communities and beyond, with collaborations spanning over a hundred private and public institutions in more than 40 countries worldwide. For further information about the Broad Institute, go to http://www.broadinstitute.org.